Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanqi Tongfeng Capsule for Gout with Hyperuricemia
CTR20160903Phase 2Terminated
- Sponsor
- Kunming Institute of Nephrology
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sanqi Tongfeng in gout, hyperuricemia, sponsored by Kunming Institute of Nephrology. Started Nov 2016; status: terminated.
02
Drugs
Sanqi Tongfeng
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20160903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160903.